Importance of protein synthesis and proteome function in aging
==============================================================

Aging is characterized by the accumulation of various forms of damage as well as by other age-related deleterious changes \[[@r1]--[@r3]\]. These changes generally have negative, deleterious consequences for organisms as they age. Different living systems differ in their metabolic strategies, resulting in different types and levels of damage production, therefore have evolved both unique and common mechanisms to counteract some of these deleterious changes. These mechanisms also limit the transfer of damage to progeny. The damage-producing and protective mechanisms are mostly genetically controlled, differ among taxonomic groups and are important in defining the lifespan of organisms. Nevertheless, the general principles of cell and organismal organization make damage accumulation inevitable for most multicellular organisms.

In this review, we discuss age-related changes in one of the most important and abundant components of any cell, and therefore of the whole organism -- the proteome. Functionality of the whole system of proteins in any organism requires maintenance of a precise balance of synthesis, degradation and function of each and every protein, while aging often shifts this balance, resulting in pathology \[[@r4]\]. Being the end-point of the implementation of genetic information, the proteome accumulates damage generated during this process. The effectiveness of proteostasis control systems, which maintain and recycle the proteome, is diminished with age, leading to the accumulation of damaged proteins and molecules, which in turn inhibit cell functionality and thus cause age-related dysfunction \[[@r5]\]. Every step in protein lifecycle, most notably protein synthesis and degradation, is relevant to the aging process and, indeed, has been shown to change with age and likely define lifespan ([Figure 1](#f1){ref-type="fig"}). While changes in protein degradation systems during aging are relatively well studied, alterations in protein synthesis still remain to be elucidated. Does the overall level of protein synthesis change with age? Which components of the translation apparatus are affected by aging? Do errors in protein synthesis increase in older organisms? Is there age-dependent regulation of protein synthesis at the level of translation? Answering these questions is necessary for understanding the mechanisms of aging and lifespan control. We will focus on them in this review.

![**Age-related changes in protein synthesis and proteostasis.** The main phases in the life of proteins are shown, with a focus on processes that change with age.](aging-10-101721-g001){#f1}

Age-related changes in protein folding and degradation
======================================================

The life of any protein in the cell begins with synthesis, which is accompanied or followed by co- or post-translational folding and modification, localization to its appropriate compartment, functioning, and, finally, degradation ([Figure 1](#f1){ref-type="fig"}). The apparatus involved in these steps is known as the proteostasis machinery. During or after synthesis, proteins adopt their intended secondary and higher-level structures in a process called folding. In most cases, folding is facilitated by the activity of chaperones and partner proteins. Decreased chaperone capacity with age was shown in numerous studies, and it is clear that it may be affected at multiple levels, including the induction of the chaperone response and chaperone activity (reviewed in \[[@r6]\]). The decision whether to degrade a protein is, among other things, influenced by the availability of ATP in the cell. Deterioration of cellular energetics with age and disruption of fatty acid and glucose metabolism reduce the amount of available ATP, changing chaperone activity and thus leading to the accumulation of damaged proteins \[[@r7]\].

Another facet of proteostasis is the control of protein aggregation, which is also facilitated by chaperones. Increased proteome stability in the form of resistance to aggregation was observed in long-lived compared to closely related shorter-lived groups of bivalve mollusks \[[@r8]\]. Comprehensive proteome profiling revealed imbalance of proteostasis components with age and an overload of chaperone machinery due to increased protein aggregation \[[@r9]\]. Accordingly, upregulation of proteostasis maintaining machinery usually has a positive effect on lifespan. Constitutive activation of the unfolded protein response (UPR) pathway through deletion of some UPR target genes increased yeast replicative lifespan via improved protein homeostasis and induction of various cytoprotective mechanisms \[[@r10]\]. In addition, slow-aging mouse models as well as mice treated with diets and drugs that extend lifespan, were found to have higher levels of ATF4 protein, a major component of the UPR pathway \[[@r11],[@r12]\]. These findings suggest a positive link between moderately elevated stress response and extended lifespan, a paradox consistent with hormesis \[[@r13]\].

Systems maintaining proteostasis are required to repair proteins damaged in the course of their lives \[[@r4],[@r5],[@r14]\]. As an example, methionine oxidation was found to increase with age \[[@r15],[@r16]\], whereas methionine sulfoxide reductases, enzymes responsible for the repair of oxidized methionines in proteins, are depleted during senescence of human fibroblasts, and aging of mice and rats \[[@r15],[@r17]--[@r20]\]. Intriguingly, proteins of the naked mole rat, *Heterocephalus glaber*, an organism with the lifespan 10-fold higher than of other rodents of similar body weight, are less susceptible to oxidative damage accumulation \[[@r21]\], despite increased levels of ROS-mediated damage at earlier stages of life of these animals. However, the levels of repair proteins, methionine sulfoxide reductase A and glutaredoxin, are similar between the mouse and the naked mole rat, and the mechanisms that support the increased resistance of the naked mole rat proteome to oxidation remain unknown.

Normal proteins that have reached the end of their lifetime, as well as damaged proteins are degraded by the autophagic and proteasome systems. Autophagy and proteasome-mediated proteolytic activity also deteriorate with age \[[@r5],[@r14],[@r22]--[@r25]\]. Their insufficient activity manifests at different levels: the proteasome assembly from its components is imbalanced and accompanied by the alterations in the ubiquitin ligation machinery and an overall reduced level of ubiquitination. In turn, autophagy is impaired both at the stage of induction and fusion of autophagosomes with lysosomes \[[@r5],[@r22],[@r26]\]. Under normal circumstances, these two systems are interconnected and can compensate for the defects in each other's function. However, aging seems to disrupt the balanced cross-talk between proteostasis modules, so the organism becomes more sensitive to stress \[[@r27],[@r28]\]. Interestingly, age-related impairment of the proteasome systems is less pronounced in long-lived species \[[@r21]\].

Synthesis and degradation of proteins are plastic and mostly tuned to achieve the appropriate protein levels and support necessary changes in response to various stimuli. Proteins are characterized by specific lifetimes, which depend on protein function, location, occurrence in complexes, metabolic status of the cell and other factors. Disruption of a normal life cycle of a protein may affect the lifespan of an organism, as well as the emergence of pathologies. Changes in the turnover rates may also lead to the accumulation and aggregation of proteins, abnormal post-translational modifications and changes of relative concentrations of various proteins, affecting stoichiometry of protein complexes \[[@r22]\]. Indeed, a number of studies have demonstrated the decreased turnover rate and increased lifetime of proteins during aging in various organisms (summarized in \[[@r29]\]). Particular long-lived proteins were shown to be retained in mother cells during yeast replicative aging and accumulated damaging modifications, possibly contributing to the aging process \[[@r30]\]. On the other hand, Yang and co-authors \[[@r31]\] found that proteins with normal life-times that were retained in mother cells during asymmetric division reduced the lifespan of the mother cell. It is important to note that yeast replicative lifespan is limited to several days, whereas many human cells persist for tens of years. Thus, spontaneous amino acid modifications and other forms of protein damage may play a much more important role in the context of human aging.

A recent study of protein turnover in the worm *Caenorhabditis elegans* confirmed the reduced turnover rates for 40% of studied proteins with age. Interestingly, the most prominent decrease was found for ribosomal proteins and proteins participating in translation regulation \[[@r32]\]. On the contrary, studies in mammals did not detect any global changes of protein turnover dynamics during aging or even identified a slight reduction in protein half-lives with age \[[@r22],[@r33],[@r34]\]. Nevertheless, in neurons altered stoichiometry of multiprotein complexes components, such as the nuclear pores, was found to be due to the decreased amounts of long-lived proteins \[[@r35]\]. Changes of turnover rates for certain groups of proteins, such as mitochondrial proteins, were also observed in the muscle \[[@r34]\]. Another well-established example of proteins that experience age-related changes are crystallins, whose damage is associated with cataract, a common age-related pathology \[[@r36]\].

Despite the fact that age-related changes in the turnover rate were not detected in mammals, protein degradation and turnover, apparently, contribute to lifespan control across species. A recent study by the Ghaemmaghami group has shown a negative correlation between the turnover rates and lifespan for eight rodent species \[[@r37]\]. In agreement with previous findings, it supports the beneficial role of decreasing the protein turnover rates in lifespan extension, probably, due to reduced energy consumption. Moreover, the observed impact of turnover on species lifespan seemed to be dependent on differences in protein sequence, but not on the function of protein degradation machinery, therefore making protein sequence another contributor to proteome stability regulation in lifespan control.

Studies of protein metabolism in the context of aging remain rather laborious and have limitations, especially in the case of complex organisms. For instance, these studies often do not account for differences in protein turnover across cellular compartments and tissues. Also, the duration of pulse labeling of a probe may not be sufficient to analyze long-lived proteins, whereas the time between labeling and fixation of tissue may be too long to determine the turnover rate of short-lived proteins \[[@r22]\]. Nevertheless, studies that succeed in identifying alterations in protein turnover with age are consistent in claiming its slow-down. Moreover, in the case of accelerated aging, an increase in turnover rates and protein synthesis was described \[[@r38]\].

Protein synthesis in aging and lifespan control
===============================================

Changes in protein synthesis rate and translation machinery with age
--------------------------------------------------------------------

Unlike changes in protein folding, maintenance and degradation, age-related alterations of protein synthesis have not yet been studied in great detail; however, some initial important observations have been made ([Figure 2](#f2){ref-type="fig"}). During the second part of the 20^th^ century, multiple studies demonstrated that the overall level of protein synthesis is reduced with age in various invertebrates, mice, rats and humans, both in different tissues and *in vitro.* These studies observed reduced ribosome abundance, attenuated activity and levels of major initiation and elongation factors (reviewed in \[[@r29],[@r39],[@r40]\]), and also a reduction in the rate of mitochondrial protein synthesis \[[@r41]\] as a function of age. The reduction in protein synthesis is probably a common feature for all living creatures; it has been observed in replicatively aged yeast \[[@r42]\], and, more recently, *in vivo* in sheep using the incorporation of a radioactive amino acid \[[@r43]\].

![**Age-related changes and lifespan modulating aspects of protein synthesis.** The eukaryotic mRNA translation cycle is shown. During translation initiation, the 43S complex is formed (top). It harbors the initiator Met-tRNAi delivered by eIF2, which is inactivated upon amino acid starvation, UPR or other stress conditions. The 43S complex is loaded onto the capped mRNA 5' end with the help of eIF4F, composed of the cap-binding protein eIF4E, a scaffold protein eIF4G, and a helicase eIF4A (not shown). The eIF4E-eIF4G interaction is inhibited by 4E-BP repressor proteins, which are activated during amino acid starvation when mTOR kinase is inactive. During elongation (right), cognate (or sometimes near-cognate) aminoacyl-tRNAs are delivered to the translating ribosome by eEF1A, followed by the peptidyl transferase reaction and eEF2-assisted translocation step (not shown). When the ribosome encounters a stop codon, translation termination occurs (bottom). At this step, the synthesized polypeptide is released by termination factor eRF1, delivered by eRF3 (not shown) and assisted by ABCE1. In some cases, however, the stop codon can be recognized by a non-cognate tRNA, leading to a readthrough event. At the final step (left), ribosome and deacylated tRNA should be removed from the mRNA (recycled) with the help of ABCE1, eIF2D and/or MCT-1/DENR proteins. Most of these events are affected by aging (light-green boxes) or linked to lifespan control (yellow boxes). Known positive and negative effects are shown by up and down arrows, respectively, while controversial or potential regulation is indicated by a question mark.](aging-10-101721-g002){#f2}

Several studies also assayed the age-related changes in the expression of genes encoding the components of the translation machinery. Reduction in the level of mRNAs encoding four large ribosome subunit proteins was observed using an RT-qPCR assay of cataract-affected lenses obtained from patients of various ages, but no difference in the mRNA levels of translation factors was found \[[@r44]\]. Nevertheless, at the protein level, reduction of translation elongation factor eEF1A abundance and activity was shown in aging adult *Drosophila melanogaster*, and this decline was suggested to be the main cause of the decreased synthesis of total protein in this case \[[@r45]\], although this conclusion was challenged by the later data \[[@r46]\]. In another study, a two-fold decrease in eEF2 protein abundance was detected in the pineal gland of old rats \[[@r47]\]. Translation elongation factors from young and old rats were also assayed in a cell-free mammalian system and found to be more active in the case of the young eEF1A, but similar for eEF2 preparations \[[@r47]\].

Aging can affect not only the abundance of translation machinery components, but also their ability to control the intracellular distribution of newly synthesized proteins. For example, a decrease in the availability of the nascent polypeptide-associated complex (NAC) due to its partial aggregation during aging may result in mistargeting of co-translationally imported mitochondrial proteins to the endoplasmic reticulum \[[@r48],[@r49]\].

As the rate and type of damage accumulation with age seems to differ for various organs and tissues \[[@r34],[@r50]--[@r57]\], changes in protein synthesis are also likely to vary. For example, one study observed an age-related reduction in total mRNA, as well as in the levels of initiation and elongation factors and RNA polymerase I protein in rat fast plantaris muscle, but not the slow soleus muscle \[[@r58]\]. It was also reported that the brain shows altered translation efficiencies for 15% of analyzed transcripts, compared to 2% in the liver \[[@r59]\].

Interestingly, the data on changes in expression of genes encoding ribosomal proteins in replicatively aged yeast are somewhat contradictory. On the one hand, increased amounts of ribosomal proteins were observed using mass-spectrometry-based proteomics \[[@r60]\], but on the other, the output of ribosomal protein mRNA translation as well as the overall translation efficiency identified with ribosome profiling were shown to decline with age \[[@r61]\]. This may indicate some defects in the degradation of ribosomes. The alterations of translation with the increasing replicative age of yeast were also confirmed by the observed gradual uncoupling of protein levels from the levels of their transcripts \[[@r60]\]. Additionally, several studies reported the disruption of the stoichiometry of translation machinery components with age \[[@r9],[@r32],[@r60]\]. Notably, the translational output, measured by ribosome profiling in the brains of young and old rats, was increased for ribosomal proteins, but decreased for translation factors, providing another example of translation machinery deregulation with age \[[@r59]\].

The abundance of ribosomes may even affect lifespan within species. The distribution of ribosomal RNA gene copy number was shown to be narrowed in the genomes of elderly humans, indicating that there may be an optimal level of ribosomal RNA required. It was hypothesized that a low copy number is not sufficient for maintaining the function of an aging organism, whereas a high copy number may also represent a disadvantage during aging, or, alternatively, the number of gene copy just decreases with age \[[@r62]\]. Somewhat similar results were obtained for *Saccharomyces cerevisiae*, where older cells with the reduced amount of ribosomal proteins exhibited a longer replicative lifespan, while in younger cells, the ribosomal protein abundance correlated positively with lifespan \[[@r63]\].

Changes of translation fidelity with age
========================================

Another important aspect of protein synthesis, which attracts the attention of researchers in the aging field, is the occurrence of translational errors, namely decoding errors and stop codon readthrough events. Attempts to assay age-related changes in translational fidelity have been made since the 1970s. The initial reports on this line of enquiry were rather controversial, unlike the data on protein synthesis and degradation. Many of them used cell-free translation systems or ribosomes isolated from organs of animals of different ages \[[@r64]--[@r66]\]. The authors of these reports were unable to detect age-related changes in translation fidelity.

Translational fidelity was also studied in extracts obtained from aging cultures of primary fibroblasts. The results of these studies were also controversial. For instance, one study noted that the number of translational errors in an extract obtained from fibroblasts that had completed around 55 doublings was 7-fold higher than that of cells which had doubled 28 times \[[@r67]\]. On the other hand, no change in translational fidelity was found in a study which investigated human skin fibroblasts obtained from healthy subjects and progeria patients and compared the fidelity of translation in cells from early and late passages \[[@r68]\]. Another study identified differences between ribosomes isolated from young and old animals. The authors used paromomycin, an aminoglycoside antibiotic, which decreases translational accuracy. Ribosomes isolated from the livers of old rats exhibited increased sensitivity to this antibiotic, i.e. after treatment with paromomycin they made 9% more errors than the ribosomes obtained from young rats \[[@r66]\].

The contradictory results of these studies may be due to the use of cell-free translation systems to assess translational fidelity \[[@r69]\]. For instance, the frequency of translation errors (misincorporation of amino acids) in yeast was estimated to be 10^-5^ \[[@r70]\]. However, estimates of fidelity from one of the most widely used systems for *in vitro* translation, rabbit reticulocyte lysate, are highly variable - from 10^-5^ \[[@r71]\] to 10^-4^ \[[@r72]\]. Such a discrepancy precludes reliable estimation of changes in translational fidelity with age. Another drawback of these early studies was the use of very specific systems to assess accuracy of amino acid incorporation, which were chosen due to the absence of more appropriate methods at the time. For instance, Luce and Bunn \[[@r67]\] used a purified mRNA encoding the coat protein of the cowpea variant of tobacco mosaic virus. This protein lacks any cysteine residues, and errors were detected using an aberrant incorporation of the labeled cysteine, while another study \[[@r65]\] assayed incorporation of leucine during the translation of a synthetic poly(U), which normally encodes poly-phenylalanine. Such systems do not recapitulate the translation of real cellular mRNAs, and the obtained estimates do not include errors in tRNA aminoacylation. Moreover, the protocol for preparing the cell-free *in vitro* translation system may introduce major changes in the parameters of protein synthesis. Thus, we should bear in mind that the shortcomings of cell-free *in vitro* systems may mask differences between studied samples. For these reasons, more recent studies aiming to assay the relation between translational fidelity and aging were performed in living cells. One study addressed changes in translation fidelity of replicatively aged yeast upon transformation of live cells with luciferase reporters \[[@r73]\]. This approach did not detect changes in translation fidelity.

The impairment of ribosome recycling was recently described in the aging mouse brains \[[@r74]\]. It was shown that the brain regions that are particularly sensitive to oxidative stress are enriched in short RNAs representing isolated 3' untranslated regions (UTR) of the regular mRNAs. These fragments are, apparently, the mRNA decay intermediates accumulated due to stalling of unrecycled ribosomes at the 3' UTRs under conditions when the ribosome recycling factor ABCE1 is damaged by oxidative stress. Translation of these RNAs results in the production of short peptides. Although the accumulation of mRNA fragments and peptides in the aging cell has not yet been shown to be a damaging factor, it likely reflects impairment of protein synthesis fidelity and could serve as a biomarker of aging.

The number of translation errors is correlated with lifespan
============================================================

Despite contradictory results on translational fidelity in aging organisms, nature has left some important clues with regard to relevance of translation fidelity to organismal aging, which was revealed by several studies that analyzed this process in various animal species \[[@r75],[@r76]\]. The naked mole rat, a rodent with an exceptionally long lifespan for its body mass, is thought to have translation fidelity nearly 10-fold higher than that of the mouse \[[@r75]\]. This study used fibroblasts isolated from the skin of mice and naked mole rats and transfected with various luciferase-based reporter constructs. They encoded firefly luciferase, but had either point mutations in the sequence, thus changing key amino acid residues, frameshifts, or premature stop-codons. Luminescence of luciferase in the cells transfected with these constructs could thus only be detected due to translation errors. The study used six constructs for assaying the following errors: three constructs for each codon position, one for readthrough and two for +1 and -1 nucleotide frameshifts. Notably, the authors used DNA-based constructs for transfection, thus the signal should be sensitive to both translation and transcription errors; however, the latter seemed to be negligible, as a clear dependence of the error rate on nucleotide position within the codon was observed. In addition to translation accuracy, the overall protein synthesis of the mouse and naked mole rat was also measured, but no difference was observed \[[@r75]\].

Using the same panel of constructs, translation fidelity was assayed in cultured primary fibroblasts of 17 rodents with different lifespan (4 to 32 years) and body weight \[[@r76]\]. The results showed that the level of error in the first and second, but not the third codon position is negatively correlated with the maximal lifespan, but not with the body weight of 16 out of the 17 species. It is possible that errors in the third (wobble) codon position are less critical, more loosely controlled and do not affect the evolution of lifespan, or that the errors are mainly due to the aminoacyl-tRNA-synthases, and not due to decoding errors by the ribosome. The rate of stop codon readthrough did not correlate with the lifespan too, suggesting a higher selective pressure for translation termination fidelity due to the high energetic cost of failing to recognize a stop codon \[[@r76]\].

In yeast, translational errors caused by antibiotics were shown to impair the folding of proteins and activate the same chaperone groups, which are activated during aging, such as Hsp104 and Hsp26 \[[@r73]\], and translation accuracy impairment induced by several methods decreased the chronological lifespan. The authors hypothesized that the increase in translational errors coupled with the increase in misfolded protein levels can overload the chaperone system, thus explaining the effect of translation errors on lifespan \[[@r73]\]. Notably, mistranslation due to the defective aminoacyl-tRNA has also been reported to be mutagenic, thus aggravating its impact in the deleteriome \[[@r77]\]. In the filamentous fungus *Podospora anserina*, strains bearing high fidelity mutations in the eEF1A gene were shown to have drastically increased longevity \[[@r78]\].

To sum up, as of now, it seems that aging is not accompanied by dramatic decreases in translational fidelity. But the large body of data that demonstrates no significant change with age is counterbalanced by indirect indications of the possible relationship, such as the sensitivity of ribosomes isolated from old animals to antibiotics, or the positive correlation between translation fidelity and maximal lifespan. As proposed by von der Haar and colleagues \[[@r73]\], it is possible that modification of translation fidelity is a factor that controls lifespan between different groups of organisms, but it seems not to play a role in lifespan plasticity of single organisms. The situation resembles that of protein turnover rate contribution to aging in mammals (see above), which is not shown to be directly altered during aging, but is negatively correlated with lifespan of rodent species \[[@r37]\].

Extending lifespan through manipulation of protein synthesis and translation-related signaling
==============================================================================================

Manipulation of translational machinery can modulate lifespan
-------------------------------------------------------------

An aging organism experiences an overall reduction of protein synthesis rates (see above). However, there is another line of evidence that highlights the importance of translation changes in aging and their effects on health. Namely, there are numerous examples of interventions affecting protein synthesis, which modulate lifespan. Sometimes, such modifications are very peculiar, as in the case of ribosomal RNA methylation at a single residue that was shown to be implicated in the control of lifespan in flies, worms and yeast \[[@r79]\]. But a notable and well established phenomenon, connecting translation with aging is that decreasing overall translation by various means can increase lifespan (reviewed in \[[@r39],[@r49],[@r80],[@r81]\]). For example, this can be done by affecting translation initiation. Deletion or downregulation of the IFE-2 somatic isoform of the initiation factor eIF4E of the worm *C. elegans* enhances the effects of pro-longevity mutations *age*, *daf, clk* and *eat* \[[@r82]\]. Downregulation of another initiation factor, eIF4G (IFG-1) increases the average lifespan of nematodes by more than 30% \[[@r83],[@r84]\], while deletion of two subunits of eIF3 results in a 40% extension \[[@r85]\]. The nematode lifespan is also improved by downregulation of one of the subunits of the eIF2B initiation factor \[[@r86]\]. A search for pro-longevity genes using RNA-interference in *C. elegans* identified ribosomal proteins and numerous components of the ribosome biosynthesis apparatus, as well as initiation factors eIF1, eIF4E, eIF4G, eIF4A, eIF2B, eIF5A and subunits of factors eIF2 и eIF3 \[[@r87]--[@r91]\]. Decreased translation level in flies achieved by acute overexpression of the regulatory factor 4E-BP lowered protein aggregation in the muscle and extended lifespan \[[@r92],[@r93]\]. Similar observations were also made in the budding yeast and filamentous fungi: a reduction in the levels of several ribosomal proteins \[[@r94]\] or factors involved in the biogenesis of the 60S ribosomal subunit \[[@r95]\] as well as mutations in translation factors \[[@r96]\] resulted in increased replicative lifespan of asymmetrically dividing *S. cerevisiae*, while mutations in some ribosomal proteins also extended lifespan in *Podospora anserina* \[[@r97]\]. Somewhat controversial results were obtained for translation elongation factors. In early studies, fruit flies with elevated expression of eEF1A were shown to live longer, while later experiments revealed no effects on lifespan (summarized in \[[@r98],[@r99]\]). For elongation factor eEF2, inhibition by EFK-1 kinase was shown to be important for the longevity of *C. elegans* both during starvation and under nutrient-rich conditions \[[@r100]\], confirming an overall positive effect of a decreased translation rate on longevity.

One of the ways in which reduced protein synthesis is thought to prolong life is the reduction of the load borne by the chaperone machinery \[[@r101]\]. Translation attenuation by the antibiotic minocycline enhances longevity and proteostasis in *C. elegans* by lowering the concentration of newly synthesized aggregation-prone proteins \[[@r102]\]. Since protein synthesis is the most energy-consuming process in the cell \[[@r103]\], its reduction could also lead to reallocation of energy to processes that repair and compensate various types of damage in the cell, as well as those that reduce damage generated in this process. Additionally, the slow-down of growth rates and consequently of the rates of protein synthesis increases the accuracy of translation, and therefore the proteome quality and stability \[[@r73]\].

Strikingly, together with the decrease in actively translating ribosomes, dietary restriction in mice decreased ribosome lifetime by almost 15% and increased rRNA and ribosomal protein turnover rates \[[@r104]\]. It appears that renewal of the intracellular ribosome pool leads to a lower level of translational errors thus improving proteostasis. In agreement with the effects of dietary restriction, rapamycin-induced inhibition of mTOR, one of the major hubs of nutrient signaling (see below), also increased ribosome turnover rates \[[@r105]\].

Mitochondrial translation contributes to longevity and lifespan control as well. In replicatively aging yeast, non-specific inhibition of mitochondrial translation \[[@r106]\], as well as deletion of mitoribosomal protein Afo1 \[[@r107]\] and the Afg3 protease involved in mitoribosome maturation \[[@r108]\] can increase replicative lifespan. It is likely that these interventions act through their effects on cytoplasmic translation and the integrated stress response pathway \[[@r109]\].

Signaling pathways controlling longevity via modulation of protein synthesis
----------------------------------------------------------------------------

Most of the established methods for increasing lifespan are based on slowing down the metabolism using dietary interventions or by affecting the molecular cascades controlling metabolism \[[@r80],[@r110]\]. These cascades stimulate overall protein synthesis, are in tight coordination with each other, and also dampen protein degradation \[[@r111]\]. [Figure 3](#f3){ref-type="fig"} depicts the molecular pathways that link the various strategies of lifespan extension with the components of the translation machinery.

![**Molecular pathways modulating lifespan via control of the translation machinery**. Components of the Ras/MEK/ERK signaling pathway are shown in yellow, those of the PI3K/Akt/mTOR axis in green, the ISR pathway in yellow, and the translation machinery components in grey \[[@r80],[@r166],[@r175],[@r180]\].](aging-10-101721-g003){#f3}

Compounds that robustly expand the lifespan of many model organisms, rapamycin and its analogs ("rapalogs") \[[@r112]--[@r115]\], affect translation via the mTORC1 signaling pathway \[[@r116],[@r117]\]. mTORC1 and mTORC2 are multiprotein kinase complexes with a shared catalytic subunit, mTOR \[[@r118]\]. The precise mechanism by which how mTORC1 affects the synthesis of translation machinery components is still unclear \[[@r119],[@r120]\], although its signaling connections, putting it in the center of the metabolic control of cell growth, have been studied extensively \[[@r111],[@r121]\].

The two main mTORC1 targets that affect translation are 4E-BP and ribosomal protein S6 kinase (p70^rsk^) \[[@r111],[@r122]\]. mTOR phosphorylates the cap-dependent translation regulators of the 4E-BP family, thus inactivating them. Direct mTOR kinase inhibitors, such as Torin1 or PP242, cause dephosphorylation of 4E-BPs and decrease translation efficiency, since the hypophosphorylated forms of 4E-BPs bind the cap-binding protein eIF4E, preventing its interaction with its partner eIF4G and other components of the translation apparatus \[[@r111],[@r119]\]. Although rapamycin is also usually considered as an mTOR inhibitor, it acts allosterically and binds to the kinase indirectly through immunophilin FKBP12, exclusively in the context of the mTORC1 complex \[[@r111]\]. Accordingly, it has different effects on mTOR targets (e.g. 4E-BP1) and overall mRNA translation than the direct (ATP-competitive) mTOR inhibitors \[[@r123]--[@r127]\] and extends lifespan even in 4E-BP-null organisms \[[@r93]\].

Another major mTORC1 target is S6 kinase which, among others, phosphorylates the S6 protein of the 40S ribosomal subunit and the eIF4B initiation factor (cofactor of the eIF4A helicase) \[[@r123],[@r124],[@r128],[@r129]\]. Relative impact of S6K and mTOR kinases on translation activation and their cross-talk in the response to extracellular stimuli are still a matter of debate (see \[[@r111],[@r127],[@r130]\] and references therein). However, it is generally accepted that signaling via mTORC1 and S6 kinase axes upregulates translation, while both rapamycin and direct mTOR inhibitors act in the opposite direction \[[@r131]\].

Changes in the mTOR pathway activity during aging is currently an ongoing research direction \[[@r132]\]. Deletion of the TOR1 gene increases replicative lifespan in yeast \[[@r94],[@r96]\]. mTOR downregulation also extends lifespan in worms \[[@r133]\] and flies \[[@r134]\]. Finally, female knockout mice heterozygous for both mTOR and another mTORC1 component, mLST8, also live longer \[[@r135]\]. However, no common trend in mTOR pathway activity changes with age could be detected in mice, as it is easily influenced by numerous environmental and intrinsic conditions (e.g. sex, tissue, feeding status) \[[@r136]\]. Nevertheless, translation downregulation caused by artificially elevated activity of 4E-BP improves proteostasis and extends lifespan in flies similarly to mTORC1 inhibition \[[@r92],[@r93],[@r137]\]. The p70^rsk^ signaling, which is connected to mTORC1, was shown to be elevated in old mice \[[@r33]\], and the animals lacking S6K1 or overexpressing dominant-negative forms of mTOR or S6K exhibited extended lifespan \[[@r134],[@r138]\].

Most components of the translation apparatus (ribosomal proteins, elongation factors, some RNA-binding proteins and translation initiation factors) contain a 5\' terminal oligopyrimidine tract (5\' TOP) at the beginning of their mRNAs \[[@r120],[@r139]\]. This specific sequence usually starts with a cytosine followed by 4 to 15 pyrimidine bases, and then by a GC-rich region. The 5\' TOP motif is highly conserved among mammals and is also found in the mRNAs of some ribosomal proteins of fruit flies; however, it has not been found in lower eukaryotes \[[@r120]\]. It is thought that the 5\' TOP sequence mediates the effect of mTORC1 on the translation of mRNAs encoding proteins of the translation apparatus \[[@r120],[@r122]\]. The current consensus on the mechanism of action of rapamycin and direct inhibitors of mTOR on cellular translation is as follows: these compounds cause a subset of mRNAs (mostly those containing 5\' TOP), which comprise up to 80% of overall translation in actively proliferating cells, to be selectively liberated from polysomes \[[@r125],[@r140]\]. One possible explanation of this phenomenon is based on the different affinity of the cap-binding protein eIF4F to the 5\' UTRs of various mRNA, as well as their competition with other mRNA-binding proteins, including those with the high affinity to the 5\' TOP motif \[[@r141]\]. TIA-1/TIAR and/or LARP1 may be the proteins that accomplish regulation of these processes in various physiologic conditions. It has been shown that TIA-1/TIAR suppress the translation of 5\' TOP mRNAs and promote their localization to stress granules during amino acid starvation \[[@r142]\]. Nevertheless, they do not mediate repression of 5\' TOP mRNA in conditions of insufficient serum or oxygen \[[@r143]\]. The data on the other factor, LARP1, are somewhat contradictory. On the one hand, it has been shown that LARP1 is associated with the mTORC1 complex and actively translating mRNAs, while downregulation of LARP1 causes selective suppression of 5\' TOP mRNA translation \[[@r144]\]. On the other hand, LARP1 directly binds the mRNA cap, competing with the assembly of eIF4F and translation initiation \[[@r145]\]. Moreover, depletion of LARP1 increases translation of 5\' TOP mRNAs and makes them resistant to inhibition by rapamycin \[[@r146],[@r147]\]. Thus, a two-step model of 5\' TOP mRNA regulation via mTORC1 is plausible. Inhibition of mTORC1 causes suppression of translation via activation of 4E-BPs and inactivation of S6K; however, different mRNAs react quite differently to this inhibition. 5\' TOP mRNA are much more sensitive to suppression, since LARP1 probably overcompetes eIF4F in binding to the 5\' TOP mRNA's termini under these conditions due to the decreased affinity of these regions to eIF4E and/or eIF4G, eIF4F components \[[@r141],[@r148],[@r149]\].

5\' TOP is not the only structural feature dictating the specific regulation of mRNAs encoding translation components. Recently, RNA-binding protein HuD was shown to regulate many mRNAs encoding mTORC1-responsive ribosomal proteins and translation factors via regulatory elements in their 3\' UTRs \[[@r150]\]. Intriguingly, mTORC1 activation also causes mRNA 3\' UTR shortening in a transcriptome-wide scale, leading to enhanced polysome recruitment of 3\' UTR-shortened transcripts \[[@r151]\]. Contrary to this, a widespread 3\' UTR lengthening of mRNAs has recently been discovered during cellular senescence \[[@r152]\]. This implies a cross-talk between mTOR-dependent regulation at transcriptional and translational levels under normal, stress and pathological conditions.

It should be noted that the mTORC1/eIF4F-mediated translational control is widely known, but it is not the only pathway regulating cellular mRNA translation. Although the highly mTOR-dependent mRNAs constitute a majority of transcripts in polysomes of actively proliferating cells, they represent just a minority of mRNA species \[[@r125],[@r140]\]. Many other mRNA species tolerate 4E-BP1 activation. They are likely to be less dependent on eIF4F and even on the 5' terminal m^7^G-cap, although still require a free 5' end to recruit the ribosome \[[@r141]\]. To explain efficient mRNA translation under these conditions, a number of alternative molecular mechanisms of ribosome recruitment were recently proposed. These include m^6^A-dependent pathways, mediated by eIF3, ABCF1 and/or YTHDF1/3 \[[@r153]--[@r156]\]; special sequences within mRNA leaders \[[@r157]\]; involvement of distinct cap-binding proteins like eIF3d \[[@r158]\], CBC (nuclear cap-binding complex) \[[@r159],[@r160]\] or unconventionally composed eIF4F variants \[[@r161],[@r162]\]; alternative RNA helicases like DDX3/Ded1p \[[@r160],[@r162],[@r163]\] or other non-canonical translation initiation mechanisms. However, their importance to aging and lifespan control are yet to be investigated, although some indirect evidence points to their putative relevance \[[@r84],[@r164]\].

Translation is also regulated through cytokine and hormone induced signaling. PI3K/AKT and MAPK pathways are activated in the presence of insulin and growth factors ([Figure 3](#f3){ref-type="fig"}). They are interconnected with the mTOR pathway and can also regulate translation in an age-dependent manner. Knockout of various components of the PI3K/Akt signaling pathway, like the insulin receptor (*daf*) genes, increases lifespan (reviewed in \[[@r165]\]). Signals from the insulin and growth factor receptors converge on a few signaling hubs, including the Akt kinase, which in turn activate mTORC1, while the kinases ERK1 and ERK2 of the MAPK-pathway activate the S6 kinase (p90^rsk^) directly \[[@r111]\]. ERK1 and ERK2 also activate the Mnk kinase, a positive regulator of translation initiation via phosphorylation of eIF4E and stabilization of its interaction with eIF4G and the 5′ cap structure. The Mnk1 kinase can be also activated by the p38 stress kinase, which is a component of the MAPK-pathway \[[@r39],[@r166]\]. Phosphorylation levels of most of the signaling molecules of this axis (ERK 1/2, p90^rsk,^ Mnk1 and p38 MAPK) were shown to be higher in muscles of older men \[[@r167]\].

Another molecular mechanism, which connects lifespan control and protein synthesis, is the integrated stress response (ISR). One of its branches is initiated by specific translational upregulation of upstream ORF-containing mRNAs encoding stress transcription factors (GCN4 in yeast and ATF4 in mammals). Lowered amino acid levels and appearance of free deacylated tRNAs in the cytoplasm activate the evolutionary conserved GCN2 kinase, which inhibits the eIF2 initiation factor by phosphorylating its α-subunit. Intriguingly, limitation for different amino acids triggers distinct signaling branches and has different effects on translation \[[@r168]--[@r170]\], thus providing a molecular basis for a variety of dietary restriction interventions with different potential to extend lifespan. In mammalian cells, three additional kinases exist that phosphorylate eIF2α under various conditions, including PERK, which is activated upon endoplasmic reticulum stress and triggers the unfolded protein response (UPR). When active eIF2α is lacking, synthesis of most proteins is suppressed; however, a peculiar arrangement of uORFs in the 5′ UTRs of the yeast GCN4 and mammalian ATF4 mRNAs, as well as of some other transcripts, allows their translational induction under these conditions \[[@r171],[@r172]\]. The transcription factors induce the expression of genes necessary for cell survival. During the ISR, mTOR kinase activity is also repressed, since a cross-talk exists between the two signaling pathways (see, for example \[[@r173],[@r174]\]). Ribosome biogenesis usually decreases while autophagy is increased during ISR, assisting proteostasis maintenance under stress conditions. Therefore, the ISR improves protein folding and maintains proteostasis \[[@r175]\], with an emerging role of mTORC1 in this process \[[@r176]\].

The role of ISR in lifespan extension is relatively well studied in yeast. GCN4 was shown to be at least partially involved in both replicative and chronological lifespan extension by various ways including depletion of nutrients and ribosomal components (reviewed in \[[@r109]\]). Elevating the ISR level is observed during aging in different species, likely because of decreased protein quality with age together with the depletion of energy resources. In replicatively aged yeast, protein synthesis was reduced due to activation of stress-induced Gcn2 kinase and by mRNA re-localization to P-bodies mediated by the Ssd1 mRNA binding protein \[[@r61]\], whereas in aged rats increased expression of ATF4 was observed in the retina, also possibly indicating induction of a protective program in response to impaired proteostasis \[[@r177]\].

Translation elongation rate is also regulated by intra- and extracellular stimuli and conditions, including starvation. AMPK, which is activated during energy depletion, phosphorylates eEF2K, a specific kinase for translation elongation factor eEF2 ([Figure 3](#f3){ref-type="fig"}). This phosphorylation leads to a decreased eEF2 translocase activity and slows down elongating ribosome velocity \[[@r111]\]. *C. elegans* deficient in EFK-1, an ortholog of eEF2K, had a shorter lifespan not only in response to starvation, but also under nutrient-rich conditions \[[@r100]\], while the increase in AMPK subunit levels, in turn, prolonged the worm's life \[[@r178]\].

CONCLUSIONS
===========

Deregulation of nutrient signaling and accumulation of damage in the aging proteome lead to decreased protein synthesis. This decrease seems to serve as an adaptation of the organism to age-related changes and may be beneficial in terms of longevity, as downregulation of protein synthesis and an increase in proteome stability are associated with increased lifespan. The effects of aging on the proteome, and more specifically, on the dynamics of protein synthesis are, as of yet, incompletely understood, and elucidation of how lifespan is controlled in various organisms and what factors shape the aging trajectory of a specific organism or its different tissues is an important goal for future studies. Currently, only a few reports have performed omics-level analyses of protein synthesis in the context of aging and nearly all of them used only two age groups (younger and older), whereas many other studies addressed changes in either highly specialized tissues, or did not compare tissues with one another. However, data on the rates of damage accumulation in different tissues \[[@r50]--[@r57]\] as well non-linear changes in transcriptomic readouts during aging \[[@r179]\] indicate that studies with more temporal resolution, i.e. more age points, involving different tissues are needed to gain a better and deeper understanding of age-related changes. In turn, these studies may help identify the important drivers of deterioration in specific tissues and pave the way for developing effective longevity interventions.
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